On the contrary, TREM2 risk variants for late-onset AD exhibit a reduced function and TREM2 inactivating mutations cause lethal early-onset dementia (i.e., Nasu–Hakola disease) [492,495]. Here, TREM2 is linked to Alzheimer disease.